LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept US$ 24.90 Min. order: 1 piece ★★★★★ 4.2 (291 reviews) Sold : Login>>
Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data | Current Obesity Reports US$ 21.94 Min. order: 1 piece ★★★★★ 4.7 (191 reviews) Sold : Login>>
Glucagon-Like Peptide-1 Based Therapies: A New Horizon in Obesity Management US$ 25.30 Min. order: 1 piece ★★★★★ 5.0 (140 reviews) Sold : Login>>
GIP mediates the incretin effect and glucose tolerance by dual actions on α cells and β cells US$ 25.65 Min. order: 1 piece ★★★★★ 4.3 (228 reviews) Sold : Login>>
⭐️Best of #DiabetesSpectrumADA2024⭐️ US$ 21.27 Min. order: 1 piece ★★★★★ 4.3 (267 reviews) Sold : Login>>